Premium
Histopathologic assessment of pancreatic cancer: Does one size fit all?
Author(s) -
Reid Michelle D.,
Bagci Pelin,
Adsay N. Volkan
Publication year - 2012
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.23194
Subject(s) - medicine , pancreas , histopathology , pancreatic cancer , adenocarcinoma , pancreatic ductal adenocarcinoma , cancer , pathology , neuroendocrine tumors , oncology
Abstract Most solid pancreatic tumors are invasive ductal adenocarcinoma (PDAC). Because PDAC is the most common tumor, it has become synonymous with the term “Pancreas Cancer.” However, other malignant neoplasms occur in the pancreas (acinar, neuroendocrine and colloid carcinomas, and metastases) all with different outcomes. Because these tumors are often combined with PDAC in research databases, it causes misleading variability in the analysis of pancreatic cancers. We examine the histopathology of a variety of pancreatic cancers. J. Surg. Oncol. 2013;107:67–77. © 2012 Wiley Periodicals, Inc.